成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 69-72-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 69-72-7
Chemical Structure| 69-72-7
Structure of 69-72-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 69-72-7 ]

Related Doc. of [ 69-72-7 ]

Alternatived Products of [ 69-72-7 ]
Product Citations

Product Citations

Hegde, Pooja ; Orimoloye, Moyosore O. ; Sharma, Sachin , et al. DOI: PubMed ID:

Abstract: Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is a leading cause of infectious disease mortality. The salicylic acid derived small mol. siderophores known as mycobactins are essential in vivo for iron acquisition of Mtb where iron is restricted in the host. Herein, we synthesize and explore the mechanism of action of polyfluorinated salicylic acid derivates, which were previously reported to possess potent antimycobacterial activity. We hypothesized fluorinated salicylic acid derivates may inhibit mycobactin biosynthesis through initial bioactivation and conversion to downstream metabolites that block late steps in assembly of the mycobactins. Enzymic studies demonstrated that some of the fluorinated salicylic acid derivatives compounds were readily activated by the bifunctional adenylating enzyme MbtA, responsible for incorporation of salicylic acid into the mycobactin biosynthetic pathway; however, they did not inhibit mycobactin biosynthesis as confirmed by LS-MS/MS using an authentic synthetic mycobactin standard Further mechanistic anal. of the most active derivative (Sal-4) using an MbtA-overexpressing Mtb strain as well as complementation studies with iron and salicylic acid revealed Sal-4 cannot be antagonized by overexpression of MbtA or through supplementation with iron or salicylic acid. Taken together, our results indicate the observed antimycobacterial activity of polyfluorinated salicylic acid derivative is independent of mycobactin biosynthesis.

Purchased from AmBeed:

Product Details of [ 69-72-7 ]

CAS No. :69-72-7 MDL No. :MFCD00002439
Formula : C7H6O3 Boiling Point : -
Linear Structure Formula :C6H4(OH)(CO2H) InChI Key :YGSDEFSMJLZEOE-UHFFFAOYSA-N
M.W : 138.12 Pubchem ID :338
Synonyms :
2-Hydroxybenzoic Acid
Chemical Name :2-Hydroxybenzoic acid

Calculated chemistry of [ 69-72-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 35.42
TPSA : 57.53 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.13
Log Po/w (XLOGP3) : 2.26
Log Po/w (WLOGP) : 1.09
Log Po/w (MLOGP) : 0.99
Log Po/w (SILICOS-IT) : 0.74
Consensus Log Po/w : 1.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.5
Solubility : 0.439 mg/ml ; 0.00318 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.109 mg/ml ; 0.000786 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.17
Solubility : 9.4 mg/ml ; 0.0681 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 69-72-7 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P201-P202-P264-P270-P280-P301+P312+P330-P305+P351+P338+P310-P308+P313-P405-P501 UN#:N/A
Hazard Statements:H302-H318-H361 Packing Group:N/A
GHS Pictogram:

Applications of [ 69-72-7 ]

Salicylic acid (CAS: 69-72-7) can be used in the preparation of Sulfasalazine (Azulfidine) (CAS: 599-79-1). Sulfasalazine is indicated for managing inflammatory diseases such as ulcerative colitis and rheumatoid arthritis (RA).

Application In Synthesis of [ 69-72-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 69-72-7 ]
  • Downstream synthetic route of [ 69-72-7 ]

[ 69-72-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 357657-22-8 ]
  • [ 56-87-1 ]
  • [ 692-04-6 ]
  • [ 1946-82-3 ]
  • [ 35436-74-9 ]
  • [ 69-72-7 ]
  • [ 50-78-2 ]
Reference: [1] Archiv der Pharmazie, 1985, vol. 318, # 2, p. 120 - 127
  • 2
  • [ 56-87-1 ]
  • [ 50-78-2 ]
  • [ 692-04-6 ]
  • [ 1946-82-3 ]
  • [ 357657-22-8 ]
  • [ 35436-74-9 ]
  • [ 69-72-7 ]
Reference: [1] Archiv der Pharmazie, 1985, vol. 318, # 2, p. 120 - 127
Recommend Products
Same Skeleton Products
Historical Records

Similar Product of
[ 69-72-7 ]

Chemical Structure| 78646-09-0

A1373046[ 78646-09-0 ]

2-Hydroxybenzoic-carboxy-13C acid

Reason: Stable Isotope

; ;